(VitalNews.org) – A new study conducted by UCLA has found that artificial intelligence tools are better at detecting cancer than doctors are. In the study, they found that an artificial intelligence tool was able to identify prostate cancer with over eighty percent accuracy compared to less than seventy percent for doctors.
Unfold AI was made by Avenda Health in California and is a software that has been approved by the Food and Drug Administration. The technology can visualize the likelihood of cancer using various forms of data through an AI algorithm. A team analyzed fifty cases where tumors have been removed with the goal of looking for residual cancer.
They looked specifically at the “negative margin rate,” which shows the absence of cancer cells surrounding the tissue. This margin rate was forty-five times greater in AI-detected cases, which shows an increase in the ability to detect cancer.
“The AI takes the information that we currently have about a patient’s prostate cancer — like their pathology, imaging, and biopsy results — and creates a 3D cancer estimation map,” said Ali Kasraeian, M.D., Kasraeian Urology urologist.
“The results we get from Unfold AI tell us if a patient will be better suited for focal therapy or more radical therapy, such as radical prostatectomy, or radiation therapy, ensuring we optimize their cancer cure, the personalization of their cancer care, and their quality of life goals,” he continued.
Joshua Trachenberg, PhD, a professor of neurobiology at UCLA and also a prostate cancer patient, spoke out about the AI discoveries. “I got in touch with a team at UCLA, where I also am a faculty member, that was exploring alternate treatments to total gland removal,” Trachenberg said.
It was determined that he was a candidate for an experimental therapy. Trachenberg said, “The 3D map created by Unfold AI-enabled this team to identify precise margins, target the cancerous area, and avoid any functional structures of the gland.”
Copyright 2024, VitalNews.org